Clinical Trial Update: Growth Hormone in the Treatment of HIV-Associated Wasting [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recombinant human growth hormone for HIV-associated wasting has completed. The sponsor was EMD Serono.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• HIV Wasting Syndrome

Drugs mentioned

• SEROSTIM (somatropin)

Snippet

Sponsor: EMD Serono | Conditions: HIV Infections, HIV Wasting Syndrome | Phase 3 | Status: COMPLETED